NYSE:AVNS Avanos Medical - AVNS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $28.54 +0.77 (+2.77%) (As of 03/20/2023 12:00 AM ET) Add Compare Share Share Today's Range$28.00▼$28.6850-Day Range$27.22▼$31.7552-Week Range$19.32▼$34.83Volume266,045 shsAverage Volume293,377 shsMarket Capitalization$1.33 billionP/E Ratio27.18Dividend YieldN/APrice Target$30.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Avanos Medical MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside5.1% Upside$30.00 Price TargetShort InterestBearish2.31% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.75Based on 6 Articles This WeekInsider TradingN/AProj. Earnings Growth19.05%From $1.68 to $2.00 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.73 out of 5 starsMedical Sector797th out of 988 stocksSurgical Appliances & Supplies Industry17th out of 22 stocks 1.0 Analyst's Opinion Consensus RatingAvanos Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $30.00, Avanos Medical has a forecasted upside of 5.1% from its current price of $28.54.Amount of Analyst CoverageAvanos Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.31% of the float of Avanos Medical has been sold short.Short Interest Ratio / Days to CoverAvanos Medical has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in Avanos Medical has recently increased by 4.95%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldAvanos Medical does not currently pay a dividend.Dividend GrowthAvanos Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AVNS. Previous Next 2.6 News and Social Media Coverage News SentimentAvanos Medical has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.35 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Avanos Medical this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 1 people have added Avanos Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avanos Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.08% of the stock of Avanos Medical is held by insiders.Percentage Held by Institutions92.08% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Avanos Medical are expected to grow by 19.05% in the coming year, from $1.68 to $2.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avanos Medical is 27.18, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 123.81.Price to Earnings Ratio vs. SectorThe P/E ratio of Avanos Medical is 27.18, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 103.57.Price to Book Value per Share RatioAvanos Medical has a P/B Ratio of 1.03. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Avanos Medical (NYSE:AVNS) StockAvanos Medical, Inc. is a medical technology company. It engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.Read More Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AVNS Stock News HeadlinesMarch 18, 2023 | americanbankingnews.comAvanos Medical (NYSE:AVNS) Research Coverage Started at StockNews.comMarch 17, 2023 | finance.yahoo.comBD's (BDX) New FDA Approval to Improve Vaginitis TestingMarch 21, 2023 | Health Sector Insight (Ad)Penny Stock Shows Big PotentialThe $4.37 trillion wellness market and the little-known penny stock to get on radar now. March 15, 2023 | finance.yahoo.comAvanos Medical, Inc. to Present at the 2023 Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor ForumMarch 14, 2023 | finance.yahoo.comOPKO Health (OPK) to Develop EBV Vaccine With Latest Tie-UpMarch 11, 2023 | americanbankingnews.comAvanos Medical (NYSE:AVNS) Raised to "Strong-Buy" at StockNews.comMarch 11, 2023 | americanbankingnews.comAvanos Medical, Inc. (NYSE:AVNS) Forecasted to Post Q1 2023 Earnings of $0.27 Per ShareMarch 10, 2023 | finance.yahoo.comReasons to Retain ShockWave Medical (SWAV) in Your PortfolioMarch 21, 2023 | Health Sector Insight (Ad)Penny Stock Shows Big PotentialThe $4.37 trillion wellness market and the little-known penny stock to get on radar now. March 10, 2023 | finance.yahoo.comBrookdale Senior (BKD) February Weighted Average Occupancy UpMarch 8, 2023 | finance.yahoo.comThree Reasons to Add BD (BDX) Stock to Your Portfolio NowMarch 6, 2023 | finance.yahoo.comAvanos Medical, Inc. Appoints Dr. Lisa Egbuonu-Davis to Board of DirectorsMarch 2, 2023 | finance.yahoo.comShould Value Investors Buy Avanos Medical (AVNS) Stock?March 1, 2023 | finance.yahoo.comOmnicell (OMCL) Q4 Earnings Beat Estimates, Margins DownFebruary 28, 2023 | finance.yahoo.comAlcon (ALC) Q4 Earnings Match Estimates, Margins ContractFebruary 24, 2023 | finance.yahoo.comWhat Makes Avanos Medical (AVNS) a New Buy StockFebruary 23, 2023 | seekingalpha.comAvanos Medical, Inc. (AVNS) Q4 2022 Earnings Call TranscriptFebruary 23, 2023 | finance.yahoo.comAvanos Medical, Inc. (NYSE:AVNS) Q4 2022 Earnings Call TranscriptFebruary 22, 2023 | msn.comLooking Into Avanos Medical's Return On Invested CapitalFebruary 22, 2023 | finance.yahoo.comAvanos Medical Full Year 2022 Earnings: In Line With ExpectationsFebruary 22, 2023 | finance.yahoo.comThe Return Trends At Avanos Medical (NYSE:AVNS) Look PromisingFebruary 22, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Halozyme (HALO) and Avanos Medical (AVNS)February 22, 2023 | finance.yahoo.comQ4 2022 Avanos Medical Inc Earnings CallFebruary 21, 2023 | msn.comAvanos Medical (AVNS) Q4 Earnings and Revenues Beat EstimatesFebruary 21, 2023 | finance.yahoo.comAvanos Medical, Inc. Announces Fourth Quarter and Full-Year 2022 ResultsFebruary 20, 2023 | msn.comEarnings Outlook For Avanos MedicalFebruary 14, 2023 | finance.yahoo.comAvanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2022 Financial ResultsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AVNS Company Calendar Last Earnings2/21/2023Today3/20/2023Next Earnings (Estimated)5/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNYSE:AVNS CUSIPN/A CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees4,044Year FoundedN/APrice Target and Rating Average Stock Price Forecast$30.00 High Stock Price Forecast$34.00 Low Stock Price Forecast$28.00 Forecasted Upside/Downside+5.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$1.05 Trailing P/E Ratio27.18 Forward P/E Ratio16.99 P/E GrowthN/ANet Income$50.50 million Net Margins6.07% Pretax Margin7.95% Return on Equity6.13% Return on Assets4.38% Debt Debt-to-Equity Ratio0.18 Current Ratio2.69 Quick Ratio1.67 Sales & Book Value Annual Sales$820 million Price / Sales1.62 Cash Flow$2.78 per share Price / Cash Flow10.26 Book Value$27.77 per share Price / Book1.03Miscellaneous Outstanding Shares46,600,000Free Float45,630,000Market Cap$1.33 billion OptionableOptionable Beta0.93 Key ExecutivesJoseph F. WoodyChief Executive Officer & Executive DirectorMichael C. GreinerChief Financial & Transformation Officer, SVPLee BurnesSenior VP-Global Research & DevelopmentMichelle ScharfenbergChief Ethics & Compliance Officer, Senior VPWilliam D. HaydonSenior VP & General Manager-Pain FranchiseKey CompetitorsEstablishment LabsNASDAQ:ESTASanara MedTechNASDAQ:SMTIEnovisNYSE:ENOVAgios PharmaceuticalsNASDAQ:AGIOCytek BiosciencesNASDAQ:CTKBView All CompetitorsInstitutional OwnershipVoya Investment Management LLCSold 387 shares on 2/28/2023Ownership: 0.285%Macquarie Group Ltd.Bought 122,247 shares on 2/21/2023Ownership: 3.522%Truist Financial CorpBought 23,124 shares on 2/17/2023Ownership: 0.050%State of WyomingSold 756 shares on 2/16/2023Ownership: 0.013%Lazard Asset Management LLCBought 575 shares on 2/15/2023Ownership: 0.013%View All Institutional Transactions AVNS Stock - Frequently Asked Questions Should I buy or sell Avanos Medical stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" AVNS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVNS, but not buy additional shares or sell existing shares. View AVNS analyst ratings or view top-rated stocks. What is Avanos Medical's stock price forecast for 2023? 2 brokers have issued 12 month target prices for Avanos Medical's stock. Their AVNS share price forecasts range from $28.00 to $34.00. On average, they anticipate the company's stock price to reach $30.00 in the next year. This suggests a possible upside of 5.1% from the stock's current price. View analysts price targets for AVNS or view top-rated stocks among Wall Street analysts. How have AVNS shares performed in 2023? Avanos Medical's stock was trading at $27.06 at the beginning of the year. Since then, AVNS stock has increased by 5.5% and is now trading at $28.54. View the best growth stocks for 2023 here. Are investors shorting Avanos Medical? Avanos Medical saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 1,010,000 shares, an increase of 10.9% from the January 31st total of 910,700 shares. Based on an average daily trading volume, of 210,300 shares, the days-to-cover ratio is presently 4.8 days. Approximately 2.2% of the company's stock are sold short. View Avanos Medical's Short Interest. When is Avanos Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023. View our AVNS earnings forecast. How were Avanos Medical's earnings last quarter? Avanos Medical, Inc. (NYSE:AVNS) posted its quarterly earnings data on Tuesday, February, 21st. The company reported $0.60 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.12. The firm had revenue of $217.50 million for the quarter, compared to the consensus estimate of $217.30 million. Avanos Medical had a net margin of 6.07% and a trailing twelve-month return on equity of 6.13%. Avanos Medical's quarterly revenue was up 12.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.46 EPS. What ETFs hold Avanos Medical's stock? ETFs with the largest weight of Avanos Medical (NYSE:AVNS) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Healthcare Technology and Innovation ETF (HTEC), First Trust Active Factor Small Cap ETF (AFSM), Pacer US Small Cap Cash Cows 100 ETF (CALF), Royce Quant Small-Cap Quality Value ETF (SQLV), First Trust Small Cap Value AlphaDEX Fund (FYT) and SPDR S&P 600 Small CapValue ETF (SLYV). What guidance has Avanos Medical issued on next quarter's earnings? Avanos Medical issued an update on its FY 2023 earnings guidance on Tuesday, February, 21st. The company provided earnings per share (EPS) guidance of $1.60-$1.80 for the period, compared to the consensus earnings per share estimate of $1.68. The company issued revenue guidance of -. What is Joseph F. Woody's approval rating as Avanos Medical's CEO? 32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Avanos Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Honeywell International (HON), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), Raytheon Technologies (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA). What is Avanos Medical's stock symbol? Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS." Who are Avanos Medical's major shareholders? Avanos Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (6.22%), RGM Capital LLC (5.71%), Macquarie Group Ltd. (3.52%), Neuberger Berman Group LLC (1.88%), Geode Capital Management LLC (1.82%) and Charles Schwab Investment Management Inc. (1.44%). Insiders that own company stock include Gary Blackford and Patrick J Oleary. View institutional ownership trends. How do I buy shares of Avanos Medical? Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Avanos Medical's stock price today? One share of AVNS stock can currently be purchased for approximately $28.54. How much money does Avanos Medical make? Avanos Medical (NYSE:AVNS) has a market capitalization of $1.33 billion and generates $820 million in revenue each year. The company earns $50.50 million in net income (profit) each year or $1.05 on an earnings per share basis. How many employees does Avanos Medical have? The company employs 4,044 workers across the globe. How can I contact Avanos Medical? Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The official website for the company is avanos.com. The company can be reached via phone at (844) 428-2667 or via email at investor.relations@avanos.com. This page (NYSE:AVNS) was last updated on 3/21/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.